• Skip to main content
  • Skip to main menu
  • Skip to main menu
  • Skip to search form
  • Candidates
  • Journalists
  • Healthcare Professionals
  • Patients
  • Innovate
    Innovate

    Discover how we create and develop new ways to provide care.

    • Pharma Innovation
    • Dermo-cosmetics R&D
    • Clinical studies
    • Medical expertise
    • Botanical expertise
    • Business Development
    Oncology pipeline
  • Care
    Care

    Sharing our desire to improve the quality of life for everyone.

    • Dermo-cosmetics
    • Oncology
    • Dermatology
    • Rare diseases
    • Chronic Diseases
    • Family health
    • Natural healthcare
    • Oral healthcare
  • Our commitments
    Our commitments

    Discover our holistic vision of health.

    • Patients
    • Environnement
    • Regions
    • Employees
    Discover the CRS report of Laboratoires Pierre Fabre
  • Our company
    Our company

    Find out more about our unique shareholding model, based around a charitable foundation.

    • Purpose
    • A global healthcare player
    • Our brands & franchises
    • Governance
    • Ethics & compliance
    • Fondation Pierre Fabre
    • History
    • News
    2025 Annual Report: Leading the way, everywhere.
  • Join us
    Join us

    Joining a company with a rich history, focused on the future of its employees.

    • Working at Pierre Fabre
    • Our Job Offers
    Join We Care Movement (new window)
  • Candidates
  • Journalists
  • Healthcare Professionals
  • Patients
  • fr
  • en

Breadcrumb

  1. Home

Your search :

212 results

The Pierre Fabre group, Platinum Sponsor at the 25th World Congress of Dermatology in Singapore
2023.07.03
Pierre Fabre unveils its ALL project: the largest international dermatology database
2023.06.20
Pierre Fabre inaugurates its new innovation center in china
2023.06.09
Même cosmetic
Pierre Fabre announces the acquisition of Même
2023.04.12
Rare disease day – february 28th, 2023
2023.02.06
Recent updates in BRAFV600E-mutant metastatic colorectal cancer treatment
2023.02.01
Creation of the Green Impact Index Consortium
2022.11.23
Pierre Fabre is taking a minority stake in Gennisium Pharma
2022.10.10
Pierre Fabre becomes the first international manufacturing group to be awarded the “Outstanding” level of the Responsibility Europe label delivered by AFNOR Certification
2022.09.28
Metastatic Colorectal Cancer World Day
2022.09.21

Pagination

  • Previous
  • …
  • Page 16
  • Page 17
  • Page 18
  • …
  • Next

Contacts & services

  • Contact us
  • Vigilance Form
  • Press area

Our brands website

  • A-Derma
  • Arthrodont
  • Darrow
  • Dexeryl gamme
  • Ducray
  • Eau Thermale Avène
  • Elgydium clinic
  • Elgydium
  • Eluday
  • Inava
  • Klorane
  • Ladrôme
  • MÊME
  • Naturactive
  • René Furterer

Follow us

  • Linkedin
  • X-Twitter
  • Linkedin Oncology
  • Instagram
  • Linkedin Primarycare
  • Facebook
  • Youtube

Useful links

  • Multimedia Resources
  • Charters & Legal documents
  • Ethics and Compliance Codes and Documents
  • Disclosure of Payments to Healthcare Professionals
  • Disclosure of Payments to Patient Organisations
  • About Laboratoires Pierre Fabre Oncology
  • About Laboratoires Pierre Fabre
  • Accessibility: partially compliant 63.93%
  • Confidentiality
  • Credits
  • Legal Information
  • Sitemap

© Laboratoires Pierre Fabre 2026

We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.

Get in touch with Pierre Fabre using your region's corporate website

International FREN

europe

  • Belgium FRNL
  • Poland
  • Denmark
  • Portugal
  • Finland
  • Spain
  • France
  • Sweden
  • Germany
  • Switzerland DEFR
  • Italy
  • Turkey
  • Norway

america

  • Brazil
  • Mexico
  • United States

asia

  • China

oceania

  • Australia